| Medicor, Ltd. |
|
| Currently, the Company has two main product lines: breast implants for aesthetic plastic and reconstructive surgery; and scar management products.
The Company’s primary product line is breast implants. The Company has a strategy of establishing or acquiring manufacturing and distribution capabilities for this product line. Historically, the Company acted as a distributor in the United States for breast implant products manufactured by a third-party manufacturer. |
|
|
Full Story... |
| New Skies Sattelites Holdings Ltd. |
|
| The Company’s satellites are used to create high-bandwidth private data networks for governments and businesses around the world. Many of these networks use relatively small antennas known as VSATs (very small aperture terminals) to connect geographically dispersed sites into a dedicated, interconnected communications network. Using such a network, individual locations can quickly, reliably and securely send and receive information directly to and from a central location. |
|
|
Full Story... |
| Medical Properties Trust, Inc. |
|
| The Company’s current portfolio of facilities consists of eight healthcare facilities, six of which are in operation and two of which are under development. The six facilities in operation, which consist of four rehabilitation hospitals and two long-term acute care hospitals, are leased to Vibra Healthcare, LLC, a recently formed specialty healthcare provider with operations in five states. The facilities under development, an acute care community hospital and an adjacent medical office building, are leased to Stealth, L. |
|
|
Full Story... |
| Epicept Corp. |
|
| The Company has six product candidates in clinical development; three in late-stage clinical development that are ready to enter, or have entered, pivotal Phase IIb or Phase III clinical trials, and three that have completed initial Phase II clinical trials.
The Company’s lead late-stage product candidate is a prescription topical analgesic cream containing a patented formulation, the contents of which include two FDA-approved drugs, amitriptyline and ketamine. |
|
|
Full Story... |
| Accuride Corp. |
|
| The Company designs, produces and markets one of the broadest portfolios of commercial vehicle components in the industry. The Company classifies its products under several categories, which include wheels, wheel-end components and assemblies, truck body and chassis parts, seating assemblies and other commercial vehicle components.
The Company is the largest North American manufacturer and supplier of wheels for heavy- and medium-duty trucks and commercial trailers. |
|
|
Full Story... |
| Verifone Holdings Inc. |
|
| The Company has designed and marketed system solutions that facilitate the long-term shift toward electronic payment transactions and away from cash and checks. The Company’s system solutions consist of point of sale electronic payment devices that run its proprietary operating systems, security and encryption software and certified payment software as well as third party, value-added applications. |
|
|
Full Story... |
| IBuyDigital.com, Inc. |
|
| The Company currently offers more than 3,000 consumer electronics products on its websites using a convenient, easy-to-use shopping interface that features extensive product information, together with pricing information and related color pictures. The Company has the capability to instantaneously change its listed products based upon customer demand and product availability.
The Company purchases products for resale both directly from manufacturers and indirectly through distributors and other sources. |
|
|
Full Story... |
| Geologistics Corp. |
|
| As a non-asset based freight forwarding and logistics services provider, the Company offers world-wide transportation services to its customers using a wide range of transportation modes, including air, ocean and overland. The Company does not own, lease or operate aircraft, ships or heavy-duty trucks. Instead, the Company contracts with commercial carriers to arrange for the shipment of its customers' goods. |
|
|
Full Story... |
| XenoPort Inc. |
|
| The Company’s most advanced product candidate, XP13512, has successfully completed a Phase 2a clinical trial for the treatment of restless legs syndrome, or RLS, and is currently being evaluated in a Phase 2a clinical trial for the management of post-herpetic neuralgia, or PHN. Each of the Company’s product candidates is an orally available, patentable new chemical entity that addresses large potential markets. |
|
|
Full Story... |
| North Pointe Holdings Corporation |
|
| Through its two insurance company subsidiaries, the Company markets both specialty commercial and personal insurance products.
The Company’s specialty commercial insurance lines consist primarily of coverages for liquor liability, property, general liability, commercial multi-peril and commercial automobiles. The Company’s insurance policies are sold to targeted small and mid-sized businesses on a single or multiple-coverage basis. |
|
|
Full Story... |
|
|
1
